Eli Lilly’s (LLY) blood cancer (leukemia) treatment called Jaypirca has shown promising results in a clinical trial. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, ...

The FDA recently approved the first drug in a new class of leukemia medicines. Kura Oncology’s endeavor to follow that newly blazed regulatory trail is now infused with $330 million from a ...

Solu Therapeutics, a company developing a new type of antibody drug, unveiled $41 million in financing on Wednesday for clinical testing of a therapy with the potential to bring a safer and more ...

WASHINGTON, Sept. 8, 2025 /PRNewswire/ -- The Leukemia & Lymphoma Society, now Blood Cancer United®, the largest global nonprofit focused on serving blood cancer patients, is launching its signature ...

After more than 75 years as the leading nonprofit advancing blood cancer research, patient support, and access to care, The Leukemia & Lymphoma Society is becoming Blood Cancer United. The new name ...

:Blood Cancer United reflects who we are today and who we aspire to be; a unifying force advancing progress for every person impacted by blood cancer." HealthDay News — In an effort to broaden the ...

Light the Night. (Copyright 2024 by KSAT - All rights reserved.) SAN ANTONIO – The organization behind the annual Light the Night event may have changed its name ...

Omeros Corporation (NASDAQ:OMER) on Thursday established the Omeros Oncology Clinical Steering Committee to advance Omeros’ OncotoX biologics program focused on acute myeloid leukemia (AML). AML is ...

In a new study presented at the American Association for Cancer Research (AACR) Annual Meeting and published in Blood Cancer Discovery, titled, “Single-cell Transcriptional Atlas of Human ...

This story is from The Pulse, a weekly health and science podcast. Find it on Apple Podcasts, Spotify, or wherever you get your podcasts. Bad advice. That’s what Jenny Ahlstrom felt like her ...